Schedule of Changes in Fair Value of Derivative Liabilities |
The
following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities:
Schedule of Changes in Fair Value of Derivative Liabilities
| |
2025 | | |
2024 | |
| |
Three months ended April 30, | |
| |
2025 | | |
2024 | |
Beginning balance | |
$ | 311,338 | | |
$ | 2,547,458 | |
Total gain | |
| (46,495 | ) | |
| (851,032 | |
Ending balance | |
$ | 264,843 | | |
$ | 1,696,426 | |
| |
| | | |
| | |
Change in fair value of derivative liabilities included in earnings relating to derivatives | |
$ | (46,495 | ) | |
$ | (851,032 | ) |
|
The
following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability:
Schedule of Changes in Fair Value of Derivative Liabilities
| |
2025 | | |
2024 | |
| |
Year Ended January 31, | |
| |
2025 | | |
2024 | |
Beginning balance | |
$ | 2,547,458 | | |
$ | 172,393 | |
Total (gains) losses | |
| (4,109,195 | ) | |
| 2,386,907 | |
Settlements | |
| (52,476 | ) | |
| (156,309 | ) |
Additions recognized as debt discount | |
| 67,352 | | |
| 146,368 | |
Additions due to tainted warrants | |
| 1,858,199 | | |
| (1,901 | ) |
Ending balance | |
$ | 311,338 | | |
$ | 2,547,458 | |
| |
| | | |
| | |
Change in unrealized (gains) losses included in earnings relating to derivatives | |
$ | (4,109,195 | ) | |
$ | 2,386,907 | |
|